Proscia Releases Commercial Research Edition of Concentriq Digital Pathology Platform

Dear Customers, Partners, and Friends,

Proscia today announced a new edition of Concentriq, our flagship digital pathology platform. The Concentriq Commercial Research Edition is a comprehensive image management solution purpose-built to help life sciences organizations better incorporate pathology data into research, discovery, and clinical trials.

While life sciences organizations have been on the forefront of digital pathology adoption in an effort to better leverage the hidden data trapped in physical glass slides, the transition to digital has introduced a new set of challenges. We regularly speak with researchers, directors, and IT personnel who almost always tell us that they are struggling to scale digital pathology across their organizations. Managing the tremendous number of images and associated data, ensuring access, and integrating with existing systems and workflows are among the most common pain points we hear.

We launched the Concentriq Commercial Research Edition to help pharmas, biotechs, and CROs realize the full promise of digitization – both today and in the years to come. With new features and enterprise scalability enhancements – including interoperability, automated metadata associations, TMA management, and hierarchical data organization schemas – we hope to empower these organizations to drive added efficiencies, fuel new insights, and ultimately maximize digital pathology investment.

For more information, I encourage you to read our latest blog, where Nathan, our Chief Product Officer, takes a deep dive into the new features. You can also find a detailed overview of our new offering here. And if you’ll be at the upcoming USCAP Annual Meeting, please respond and let me know. We welcome the opportunity to share all that we’ve been up to in-person at the event.

As always, thanks for your continued support.

Best,
David West
CEO, Proscia

Source: Proscia Inc.